This is the authors' abstract. We don't add key points for this paper.
Purpose Autoimmune encephalitis (AE) and infectious encephalitis (IE) share a presenting syndrome but require opposing treatment, often before antibody results are available. We compared children with AE and IE and developed a bedside score to distinguish them at presentation. Methods Children aged 0–18 years with AE or infectious encephalitis/meningoencephalitis admitted to a tertiary centre in Riyadh, Saudi Arabia (January 2020–July 2026) were retrospectively compared. A score derived by logistic regression from pre-serological variables underwent bootstrap, temporal, and subgroup validation and was compared with an adapted adult-derived (Granillo) score. Results Of 214 eligible children, 22 met both definitions; of the remaining 192 (70 AE, 122 IE), those with AE were older (median 9.2 vs 0.7 years) and more often had psychiatric or behavioural symptoms (51.4% vs 4.1%) and a normal cerebrospinal fluid (CSF) white cell count (84.1% vs 24.7%; both p < 0.001); seizures were equally frequent (49.3% vs 49.2%). Only 17.5% of children with AE, versus 64.2% with IE, were diagnosed within 1 week. The King Fahad Medical City (KFMC) AE-IE Score (age, psychiatric or behavioural symptoms, normal CSF cell count) achieved an area under the receiver operating characteristic curve of 0.93, outperformed the adapted Granillo score (0.89; p = 0.012), and retained discrimination in children aged ≥ 2 years (0.87) and in consensus-defined encephalitis (0.97). A score ≥ 10 had 83% sensitivity and 91% specificity. Conclusion Simple features available at presentation distinguish paediatric AE from IE. The KFMC AE-IE Score requires prospective external validation.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kateb et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: